Evidence map›Paper›PMID 34976231›Full record

ReviewBehavioural neurology2021

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders.

Chrysi Petsani, Athina-Maria Aloizou, Vasileios Siokas, Lambros Messinis, Eleni Peristeri, Christos Bakirtzis, Grigorios Nasios, Efthimios Dardiotis

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Behavioural neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chrysi PetsaniDepartment of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, Larissa, Greece.
Athina-Maria AloizouDepartment of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, Larissa, Greece.
Vasileios SiokasDepartment of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, Larissa, Greece.
Lambros MessinisSchool of Psychology, Lab of Cognitive Neuroscience, Aristotle University of Thessaloniki, Greece.
Eleni PeristeriDepartment of English Studies, Aristotle University of Thessaloniki, Greece.ORCID https://orcid.org/0000-0001-9629-0193
Christos BakirtzisMultiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Grigorios NasiosDepartment of Speech and Language Therapy, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Efthimios DardiotisDepartment of Neurology, University Hospital of Larissa, School of Medicine, University of Thessaly, Larissa, Greece.ORCID https://orcid.org/0000-0003-2957-641X
University of Thessaly · GRAristotle University of Thessaloniki · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies (LBD). APDs are characterized by a variety of symptoms and a lack of disease modifying therapies; their treatment thus remains mainly symptomatic. Brain stimulation via repetitive transcranial magnetic stimulation (rTMS) is a safe and noninvasive intervention using a magnetic coil, and it is considered an alternative therapy in various neuropsychiatric pathologies. In this paper, we review the available studies that investigate the efficacy of rTMS in the treatment of these APDs and Parkinson plus syndromes.

Indexed as

Corticobasal DegenerationMultiple System AtrophyParkinsonian DisordersSupranuclear Palsy, ProgressiveHumansRandomized Controlled Trials as TopicTranscranial Magnetic Stimulation

Identifiers

PMID34976231
PMCPMC8718319
OpenAlexW4200163627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.